HDAC as a therapeutic target for treatment of endometrial cancers.
Ren J, Zhang J, Cai H, Li Y, Zhang Y, Zhang X, Zhao D, Li Z, Ma H, Wang J, Gao YE, Xiao L, Liu R, Qian J, Liu Y, Wei H, Li J.
Ren J, et al.
Curr Pharm Des. 2014;20(11):1847-56. doi: 10.2174/13816128113199990528.
Curr Pharm Des. 2014.
PMID: 23888962
Review.